. Author manuscript; available in PMC: 2012 Feb 29.

Published in final edited form as: J Acquir Immune Defic Syndr. 2010 Oct;55(2):189–196. doi: 10.1097/QAI.0b013e3181e46308

Table 2.

HIV-infected children on HAART with protective anti-influenza MN titers (≥40) before and after vaccination with TIV or LAIV.

Viral strains	Week	LAIV	TIV	p-value^*
A H1N1 New Caledonia	0	88% (103/117)	86% (100/116)	0.70
	4	96% (109/114)	100% (109/109)	0.06
	24	96% (106/110)	97% (111/114)	0.72
A H3N2 Wyoming	0	100% (114/114)	99% (113/114)	1.00
	4	100% (104/104)	100% (104/104)	N.A.
	24	100% (100/100)	100% (107/107)	N.A.
B Jilin	0	66% (75/113)	72% (84/117)	0.39
	4	81% (86/106)	88% (95/108)	0.19
	24	80% (82/103)	84% (97/115)	0.38

Fisher’s exact test